Schnaper H William
Division of Kidney Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
Adv Chronic Kidney Dis. 2017 Mar;24(2):107-116. doi: 10.1053/j.ackd.2016.11.011.
Accumulating evidence suggests that the central locus for the progression of CKD is the renal proximal tubule. As injured tubular epithelial cells dedifferentiate in attempted repair, they stimulate inflammation and recruit myofibroblasts. At the same time, tissue loss stimulates remnant nephron hypertrophy. Increased tubular transport workload eventually exceeds the energy-generating capacity of the hypertrophied nephrons, leading to anerobic metabolism, acidosis, hypoxia, endoplasmic reticulum stress, and the induction of additional inflammatory and fibrogenic responses. The result is a vicious cycle of injury, misdirected repair, maladaptive responses, and more nephron loss. Therapy that might be advantageous at one phase of this progression pathway could be deleterious during other phases. Thus, interrupting this downward spiral requires narrowly targeted approaches that promote healing and adequate function without generating further entry into the progression cycle.
越来越多的证据表明,慢性肾脏病进展的核心部位是肾近端小管。当受损的肾小管上皮细胞在试图修复时发生去分化,它们会刺激炎症反应并募集肌成纤维细胞。与此同时,组织损伤会刺激残余肾单位肥大。增加的肾小管转运工作量最终会超过肥大肾单位的能量生成能力,导致无氧代谢、酸中毒、缺氧、内质网应激,并引发更多的炎症和纤维化反应。结果是损伤、错误修复、适应性不良反应和更多肾单位丢失的恶性循环。在这一进展途径的一个阶段可能有益的治疗,在其他阶段可能有害。因此,打断这种恶性循环需要精准靶向的方法,以促进愈合和充分发挥功能,同时不会进一步进入进展循环。